Literature DB >> 11249912

Plasma levels of vascular endothelial growth factor and its soluble receptor (SFlt-1) in essential hypertension.

F M Belgore1, A D Blann, F L Li-Saw-Hee, D G Beevers, G Y Lip.   

Abstract

In this study of 27 untreated patients with uncomplicated essential hypertension, we report on elevated plasma levels of vascular endothelial growth factor and its soluble receptor Flt-1 compared with healthy controls; these increased levels are reduced by the treatment of hypertension. This raises the possibility that abnormal angiogenesis may contribute to the pathogenesis of complications related to hypertension and merits exploration in larger studies.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11249912     DOI： 10.1016/s0002-9149(00)01512-5

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  33 in total

1.  The vascular marker soluble fms-like tyrosine kinase 1 is associated with disease severity and adverse outcomes in chronic heart failure.

Authors:  Bonnie Ky; Benjamin French; Kosha Ruparel; Nancy K Sweitzer; James C Fang; Wayne C Levy; Douglas B Sawyer; Thomas P Cappola
Journal:  J Am Coll Cardiol       Date:  2011-07-19       Impact factor: 24.094

2.  Analysis of the correlation among hypertension, the intake of β-blockers, and overall survival outcome in patients undergoing chemoradiotherapy with inoperable stage III non-small cell lung cancer.

Authors:  Pei Yang; Weiye Deng; Yaqian Han; Yingrui Shi; Ting Xu; Juan Shi; Hesham Elhalawani; Yu Zhao; Xiaoxue Xie; Fan Lou; Rong Zhang; Hekun Jin
Journal:  Am J Cancer Res       Date:  2017-04-01       Impact factor: 6.166

3.  Circulating vascular growth factors and central hemodynamic load in the community.

Authors:  Justin P Zachariah; Vanessa Xanthakis; Martin G Larson; Joseph A Vita; Lisa M Sullivan; Holly M Smith; Radwan Safa; Xuyang Peng; Naomi Hamburg; Daniel Levy; Douglas B Sawyer; Gary F Mitchell; Ramachandran S Vasan
Journal:  Hypertension       Date:  2012-02-27       Impact factor: 10.190

4.  Eplerenone suppresses salt-induced vascular endothelial growth factor expression in the kidney.

Authors:  Danita Eatman; Mohammed F Layas; Mohamed A Bayorh
Journal:  Kidney Blood Press Res       Date:  2010-06-23       Impact factor: 2.687

5.  Maternal and fetoplacental hypoxia do not alter circulating angiogenic growth effectors during human pregnancy.

Authors:  Stacy Zamudio; Marcus Borges; Lourdes Echalar; Olga Kovalenko; Enrique Vargas; Tatiana Torricos; Abdulla Al Khan; Manuel Alvarez; Nicholas P Illsley
Journal:  Biol Reprod       Date:  2014-02-27       Impact factor: 4.285

6.  Ceramide-activated phosphatase mediates fatty acid-induced endothelial VEGF resistance and impaired angiogenesis.

Authors:  Vishal C Mehra; Elias Jackson; Xian M Zhang; Xian-Cheng Jiang; Lawrence W Dobrucki; Jun Yu; Pascal Bernatchez; Albert J Sinusas; Gerald I Shulman; William C Sessa; Timur O Yarovinsky; Jeffrey R Bender
Journal:  Am J Pathol       Date:  2014-03-05       Impact factor: 4.307

Review 7.  A Review of Angiogenic Imbalance in HIV-Infected Hypertensive Disorders of Pregnancy.

Authors:  Sayuri Padayachee; Jagidesa Moodley; Thajasvarie Naicker
Journal:  Curr Hypertens Rep       Date:  2019-07-24       Impact factor: 5.369

Review 8.  Heart failure associated with sunitinib: lessons learned from animal models.

Authors:  Colin F Greineder; Sarah Kohnstamm; Bonnie Ky
Journal:  Curr Hypertens Rep       Date:  2011-12       Impact factor: 5.369

9.  A common variant highly associated with plasma VEGFA levels also contributes to the variation of both LDL-C and HDL-C.

Authors:  Maria G Stathopoulou; Amélie Bonnefond; Ndeye Coumba Ndiaye; Mohsen Azimi-Nezhad; Said El Shamieh; Abdelsalam Saleh; Marc Rancier; Gerard Siest; John Lamont; Peter Fitzgerald; Sophie Visvikis-Siest
Journal:  J Lipid Res       Date:  2012-12-02       Impact factor: 5.922

10.  Vascular endothelial growth factor, its soluble receptor, and hepatocyte growth factor: clinical and genetic correlates and association with vascular function.

Authors:  Wolfgang Lieb; Radwan Safa; Emelia J Benjamin; Vanessa Xanthakis; Xiaoyan Yin; Lisa M Sullivan; Martin G Larson; Holly M Smith; Joseph A Vita; Gary F Mitchell; Douglas B Sawyer; Ramachandran S Vasan
Journal:  Eur Heart J       Date:  2009-02-17       Impact factor: 29.983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.